Journals / E Journal of Cardiovascular Medicine / 2021 / Cilt: 9 - Sayı: 3

Do Cardiological Characteristics Explain the Mortality Rate Disparity Between Genders in COVID-19?

Pages
169–177
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

High-sensitive troponin T, presentative of myocardial injury, was considerably higher in dead patients than survivors (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The coronavirus disease-2019 (COVID-19) mortality risk in males is twice as high compared to females.
📊
Key Findings & Data:The literature lacks data regarding how the cardiological parameters influence the mortality rate imbalance between genders in the setting of COVID-19.
💡
Conclusion & Impact:High-sensitive troponin T, presentative of myocardial injury, was considerably higher in dead patients than survivors (p
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: The coronavirus disease-2019 (COVID-19) mortality risk in males is twice as high compared to females. The literature lacks data regarding how the cardiological parameters influence the mortality rate imbalance between genders in the setting of COVID-19. This study aims to investigate how cardiological parameters vary between genders in COVID-19 disease—a potential explanation for the increased mortality rate in males in the setting of COVID-19. Materials and Methods: We included 458 adult patients with a confirmed diagnosis of COVID-19 disease. Demographics, comorbidities, laboratory findings, and electrocardiogram parameters were compared between males and females. Results: Of 458, a total of 63 (14.2%) patients died, and 82 (17.9%) were followed up in the intensive care unit during the hospitalization. Although the median age between males and females looked like to be similar, the mortality rate was significantly higher among males (44% vs 9.5%, p=0.006). High-sensitive troponin T, presentative of myocardial injury, was considerably higher in dead patients than survivors (p

🔖

Cite This Article

PERİNCEK, G., KARAYAKALI, M., OMAR, T. (2022). Do Cardiological Characteristics Explain the Mortality Rate Disparity Between Genders in COVID-19?. E Journal of Cardiovascular Medicine, Cilt: 9 - Sayı: 3, 169–177. https://ajindex.com/articles/498212

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. World Health Organisation (WHO) Available at: https://www.who.int/ emergencies/diseases/novel-coronavirus-2019 (Accessed: 15.07.2021)
  2. Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 2020;116:1666-87
  3. Fried JA, Ramasubbu K, Bhatt R, et al. The Variety of Cardiovascular Presentations of COVID-19. Circulation 2020;141:1930-6
  4. South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol 2020;318:H1084-90
  5. Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020;584:430-6
  6. Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ 2020;11:29
  7. Bienvenu LA, Noonan J, Wang X, Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res 2020;116:2197-206
  8. Surawicz B, Knilans T. Chou’s Electrocardiography in Clinical Practice. 6th ed. Saunders; 2008
  9. Ahmed SB, Dumanski SM. Sex, gender and COVID-19: a call to action. Can J Public Health 2020;111:980-3
  10. Bhopal SS, Bhopal R. Sex differential in COVID-19 mortality varies markedly by age. Lancet 2020;396:532-3
  11. Goyal P, Choi JJ, Pinheiro LC, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med 2020;382:2372-4
  12. De Vita A, Ravenna SE, Covino M, et al. Electrocardiographic Findings and Clinical Outcome in Patients with COVID-19 or Other Acute Infectious Respiratory Diseases. J Clin Med 2020;9:3647
  13. Li L, Zhang S, He B, Chen X, Wang S, Zhao Q. Risk factors and electrocardiogram characteristics for mortality in critical inpatients with COVID-19. Clin Cardiol 2020;43:1624-30
  14. Farré N, Mojón D, Llagostera M, et al. Prolonged QT Interval in SARSCoV- 2 Infection: Prevalence and Prognosis. J Clin Med 2020;9:2712
  15. Romero J, Alviz I, Parides M, et al. T-wave inversion as a manifestation of COVID-19 infection: a case series. J Interv Card Electrophysiol 2020;59:485-93
  16. Abrams MP, Wan EY, Waase MP, et al. Clinical and cardiac characteristics of COVID-19 mortalities in a diverse New York City Cohort. J Cardiovasc Electrophysiol 2020;31:3086-96
  17. Ghio S, Baldi E, Vicentini A, et al. Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a